Figure 3.
Figure 3. Overview on timing of cellular immunotherapies to improve immunity after allo-HCT. iNKT, invariant NKT; TRM, transplantation-related mortality.

Overview on timing of cellular immunotherapies to improve immunity after allo-HCT. iNKT, invariant NKT; TRM, transplantation-related mortality.

Close Modal
This Feature Is Available To Subscribers Only

or Create an Account

Close Modal
Close Modal